Welcome to World Journal of Obstetrics and Gynecology


The World Journal of Obstetrics and Gynecology (WJOG) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of obstetrics and gynecology.  It was launched on June 10, 2012 and is published trimonthly (4 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.


We encourage gynecologists worldwide to submit manuscripts to the WJOG describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.


The usual times related to all publication processes of the WJOG are as follows: from manuscript receipt to peer review: 2-4 weeks; from initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; from return of the revised manuscript from the authors to final acceptance: 1-2 weeks; from final acceptance to an article in press: 2 days; from article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJOG’s acceptance rate: 50%. Submit here >>

Published Issues

Alfonso Duenas-Gonzalez, MD, PhD, Doctor; Bo Jacobsson, MD, PhD, Professor


There is currently no indexing/abstracting.

Impact Factor

There is currently no impact factor.


2218-6220 (online)

Previous  |   Next  |   Latest  |   Archive
Contents Volume 5  Issue 1  February 10, 2016
Clinical applicability of immunotherapy of cervical intraepithelial neoplasia  
Margot Koeneman, Roy Kruitwagen, Arnold-Jan Kruse
World J Obstet Gynecol 5(1):1-4. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.1
Update on human papillomavirus vaccination: Where are we now?  
Eloise Chapman-Davis, Lauren E Dockery, Kendall Griffith, Caroline Stroup
World J Obstet Gynecol 5(1):5-15. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.5
Human papilloma virus vaccination: Review article and an update  
Zahra Maleki
World J Obstet Gynecol 5(1):16-27. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.16
MicroRNAs: New players in endometriosis  
Josep Marí-Alexandre, Moisés Barceló-Molina, María Olcina-Guillem, Javier García-Oms, Aitana Braza-Boïls, Juan Gilabert-Estellés
World J Obstet Gynecol 5(1):28-38. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.28
Pathobiological role of MUC16 mucin (CA125) in ovarian cancer: Much more than a tumor biomarker  
Alain Piché
World J Obstet Gynecol 5(1):39-49. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.39
Implications of multigene testing for hereditary breast cancer in primary care  
Meghna S Trivedi, Katherine D Crew
World J Obstet Gynecol 5(1):50-57. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.50
Amniocentesis: A contemporary review  
Katherine Ann Connolly, Keith Arnold Eddleman
World J Obstet Gynecol 5(1):58-65. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.58
Thyroid disease in pregnancy: A review of diagnosis, complications and management  
Lisa E Moore
World J Obstet Gynecol 5(1):66-72. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.66
Role of ultrasound imaging in advancing treatment of female patients with pelvic floor mesh complications  
William Singh, Harpreet Wadhwa, Whitney Halgrimson, Ervin Kocjancic
World J Obstet Gynecol 5(1):73-77. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.73
Evaluation of sentinel lymph nodes in vulvar, endometrial and cervical cancers  
Jenna Emerson, Katina Robison
World J Obstet Gynecol 5(1):78-86. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.78
Apoptosis and endometrial receptivity: Relationship with in vitro fertilization treatment outcome  
Yulia S Antsiferova, Natalya Y Sotnikova
World J Obstet Gynecol 5(1):87-96. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.87
Review of the current surgical management of vulval cancer  
Sarah L Platt, Kristyn M Manley, John B Murdoch
World J Obstet Gynecol 5(1):97-101. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.97
Imperative for improvements and international convergence of intrapartum fetal monitoring: A bird’s eye view  
Shashikant L Sholapurkar
World J Obstet Gynecol 5(1):102-109. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.102
Overview of embryonal rhabdomyosarcoma of cervix in women over 40-year-old  
Malala Razakanaivo, Nam P Nguyen, Juliette Thariat, Vincent Molinie, Anne-Therese Vlastos, Claire Verschraegen, Vincent Vinh-Hung
World J Obstet Gynecol 5(1):110-117. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.110
Basic Study
Alpha1B adrenoceptor expression is a marker of reduced survival and increased tumor recurrence in patients with endometrioid ovarian cancer  
Dascha Deutsch, Suha Deen, Frank Entschladen, Clare Coveney, Robert Rees, Kurt S Zänker, Desmond George Powe
World J Obstet Gynecol 5(1):118-126. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.118
Observational Study
Variation in use of menopausal hormone treatment on risk of health outcomes  
Soo-Keat Khoo, Lee Tripcony
World J Obstet Gynecol 5(1):127-133. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.127
Systematic Reviews
Postpartum intrauterine device contraception: A review  
Shadi Rezai, Pameela Bisram, Hasan Nezam, Ray Mercado, Cassandra E Henderson
World J Obstet Gynecol 5(1):134-139. Published online Feb 10, 2016. doi: 10.5317/wjog.v5.i1.134